We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$165B
AUM Growth
-$22.2B
Cap. Flow
-$11.2B
Cap. Flow %
-6.82%
Top 10 Hldgs %
27.67%
Holding
6,926
New
1,006
Increased
1,821
Reduced
3,025
Closed
497

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$852M
2
MSFT icon
Microsoft
MSFT
+$575M
3
CVNA icon
Carvana
CVNA
+$540M
4
TGT icon
Target
TGT
+$430M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$376M

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Financials 5.96%
3 Consumer Discretionary 5.3%
4 Healthcare 4.99%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOTV
5126
DELISTED
Inotiv
NOTV
$16K ﹤0.01%
626
-3,165
-83% -$88.9K
PPH icon
5127
VanEck Pharmaceutical ETF
PPH
$987M
$16K ﹤0.01%
200
REKR icon
5128
Rekor Systems
REKR
$86.9M
$16K ﹤0.01%
3,556
-5,782
-62% -$27.2K
RMNI icon
5129
Rimini Street
RMNI
$453M
$16K ﹤0.01%
2,711
-9,399
-78% -$49.4K
RXL icon
5130
ProShares Ultra Health Care
RXL
$89.3M
$16K ﹤0.01%
320
RZG icon
5131
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$143M
$16K ﹤0.01%
348
VKTX icon
5132
Viking Therapeutics
VKTX
$3.93B
$16K ﹤0.01%
5,189
-183,270
-97% -$657K
YANG icon
5133
Direxion Daily FTSE China Bear 3X ETF
YANG
$89M
$16K ﹤0.01%
+50
New +$20.3K
OMGA
5134
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$16K ﹤0.01%
2,622
-759
-22% -$7.75K
FUV
5135
DELISTED
Arcimoto, Inc. Common Stock
FUV
$16K ﹤0.01%
123
-258
-68% -$33.5K
LIBYW
5136
CALL
DELISTED
Liberty Resources Acquisition Corp. Warrant
LIBYW
$16K ﹤0.01%
+68,001
New +$16.3K
IRRX.WS
5137
CALL
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
$16K ﹤0.01%
+50,001
New +$16.7K
LMDXW
5138
CALL
DELISTED
LumiraDx Limited Warrant
LMDXW
$16K ﹤0.01%
20,058
AMTI
5139
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$16K ﹤0.01%
2,101
-7,199
-77% -$59.6K
ALORW
5140
CALL
DELISTED
ALSP Orchid Acquisition Corp I Warrant
ALORW
$16K ﹤0.01%
+62,501
New +$18K
CPTN
5141
DELISTED
Cepton, Inc. Common Stock
CPTN
$16K ﹤0.01%
+401
New +$35.8K
BLU
5142
DELISTED
BELLUS Health Inc.
BLU
$16K ﹤0.01%
2,311
-86
-4% -$554
VPCBW
5143
CALL
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
$16K ﹤0.01%
+51,447
New +$24.3K
TSPQ.WS
5144
CALL
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$16K ﹤0.01%
+50,173
New +$19.1K
SMTS
5145
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$16K ﹤0.01%
+13,200
New +$17.8K
ESTE
5146
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$16K ﹤0.01%
1,291
-5,422
-81% -$70.7K
ALGS icon
5147
Aligos Therapeutics
ALGS
$26.3M
$15K ﹤0.01%
278
-23
-8% -$1.84K
AMLX icon
5148
Amylyx Pharmaceuticals
AMLX
$2.17B
$15K ﹤0.01%
+1,154
New +$26.1K
AP icon
5149
Ampco-Pittsburgh
AP
$167M
$15K ﹤0.01%
2,314
ARDX icon
5150
Ardelyx
ARDX
$1.25B
$15K ﹤0.01%
14,150
-22,258
-61% -$19.9K

Similar funds

Citigroup's Q1 2022 Portfolio in Review

As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.

  • Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
  • Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
  • Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
  • Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
  • Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
  • Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.